Werner Lanthaler

Werner Lanthaler

No open positions remaining
58 year
Health Technology
Commercial Services
Consumer Services

Profile

Currently, Werner Lanthaler is Chief Executive Officer for Evotec SE. He is also on the board of AC Immune SA, argenx SE, Evotec (UK) Ltd. and Topas Therapeutics GmbH (former Chairman-Supervisory Board). In his past career Dr. Lanthaler held the position of Chief Financial Officer for Intercell AG. He received a doctorate and an undergraduate degree from the University of Vienna and a graduate degree from Harvard University.

Werner Lanthaler active positions

CompaniesPositionStart
Director/Board Member 19/03/2009
Chief Executive Officer -
Chief Executive Officer 08/10/2025

Former positions of Werner Lanthaler

CompaniesPositionEnd
AC IMMUNE SA Director/Board Member 19/06/2025
EVOTEC SE Chief Executive Officer 03/01/2024
ARGENX SE Director/Board Member 27/02/2023
Chairman -
Director/Board Member 01/01/2013
See the detail of Werner Lanthaler's experience

Training of Werner Lanthaler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Commercial Services

Retail Trade

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Werner Lanthaler